Moleculin Biotech, Inc. (MBRX) Social Stream
MOLECULIN BIOTECH INC (MBRX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering MOLECULIN BIOTECH INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-18 | 3 | $29 | $10 | $19 | $0.84 | 2161.9% |
| 2022-04-11 | 3 | $29 | $10 | $18 | $0.84 | 2042.86% |
| 2022-08-15 | 3 | $29 | $5 | $16 | $0.84 | 1804.76% |
| 2022-08-16 | 3 | $16 | $5 | $11.666 | $0.84 | 1288.81% |
| 2023-03-23 | 3 | $16 | $5 | $8.666 | $0.84 | 931.67% |
| 2023-08-20 | 2 | $16 | $5 | $10.5 | $0.84 | 1150% |
| 2023-11-13 | 3 | $16 | $3 | $9.5 | $0.84 | 1030.95% |
| 2023-12-14 | 3 | $16 | $3 | $7.333 | $0.84 | 772.98% |
The Trend in the Analyst Price Target
Over the past 43 months, MBRX's average price target has gone up $4.
MBRX reports an average of 1,238.32% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-23 | 3 | 16 | 5 | 10.5 | 0.943 | 1013.47% |
| 2023-05-02 | 2 | 16 | 5 | 10.5 | 0.800 | 1212.5% |
| 2023-05-11 | 2 | 16 | 5 | 10.5 | 0.752 | 1296.28% |
| 2023-08-20 | 2 | 16 | 5 | 10.5 | 0.553 | 1798.73% |
| 2023-11-13 | 2 | 16 | 3 | 8.0 | 0.576 | 1288.89% |
MBRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 16 months, MBRX's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MBRX as an investment opportunity.
- In terms of how MOLECULIN BIOTECH INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1172.12% of that group.
- In the context of all US stocks, MOLECULIN BIOTECH INC's number of analysts covering the stock is greater than 79.46% of them.
- In terms of how MOLECULIN BIOTECH INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1013.69% of that group.
- MOLECULIN BIOTECH INC's average analyst price target is higher than 253.27% of Healthcare stocks.
Stocks similar to MOLECULIN BIOTECH INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ENLV, AKTX, and HEPA.
View All Top Stocks by Price Target
Is MBRX a Buy, Hold or Sell? See the POWR Ratings now!